Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel. The Company operates in four segments: Endo Pharmaceuticals, Qualitest, AMS, and HealthTronics. Through the Company's HealthTronics segment, the Company provides lithotripsy services, prostate treatment services, anatomical pathology services, medical products manufacturing, sales and maintenance, and information technology solutions. Its products in the Qualitest portfolio includes Endocet, Morphine Sulfate ER, and Hydrocodone. Its AMS products include AMS 700 MS, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, and Monarc subfascial hammock. Its Endo Pharmaceuticals products include Lidoderm, Opana ER, Voltaren Gel, and Percocet.
|Headquarters||1400 Atwater Drive|
MALVERN, PA, United States 19317
|Independent Chairman of the Board||Roger Kimmel|
|President, Chief Executive Officer, Director||Rajiv De Silva|
|Chief Financial Officer, Executive Vice President||Alan Levin|
|President of American Medical Systems Inc.||Camille Farhat|
|Chief Operating Officer||Julie McHugh|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||112.2M||Book Value||$9.68|
|Annual Dividend Rate||$0.00||Price/Sales (TTM)||1.2|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||-13.48%|
*GAAP = prior to non-GAAP analyst adjusted earnings.